Antibodies persisted 6 months after the second dose of Moderna's COVID-19 vaccine in younger and middle-age adults, but were diminished in older adults when using more sensitive assays, according to data from an ongoing phase I trial.
The National Institutes of Health (NIH) announced Wednesday that it's launching a study to gauge the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals.
As the world struggles to break the grip of COVID-19, psychologists and misinformation experts are studying why the pandemic spawned so many conspiracy theories, which have led people to eschew masks, social distancing and vaccines.
...Around the country, businesses, schools and politicians are considering “vaccine passports” — digital proof of vaccination against the coronavirus — as a path to reviving the economy and getting Americans back to work and play. Businesses especially fear that too many customers will stay away unless they can be assured that the other patrons have been inoculated.
But the idea is raising charged legal and ethical questions: Can businesses require employees or customers to provide proof — digital or otherwise — that they have been vaccinated when the coronavirus vaccine is ostensibly voluntary?
NEW DELHI (AP) — The world’s largest vaccine maker, based in India, will be able to restart exports of AstraZeneca doses by June if new coronavirus infections subside in the country, its chief executive said Tuesday.
Six months after being diagnosed with Covid-19, 1 in 3 patients also had experienced a psychiatric or neurological illness, mostly mood disorders but also strokes or dementia, a large new study shows.
Last Saturday, the U.S. hit a new high for the number of daily vaccinations: 4 million. The record day came as vaccinations have steadily risen over recent weeks, bringing the daily average to more than 3 million.
Nearly half of new coronavirus infections nationwide are in just five states — a situation that is putting pressure on the federal government to consider changing how it distributes vaccines by sending more doses to hot spots.
Public health experts, general practitioners and pediatricians had warned for months that a surge in coronavirus cases over the winter months would be compounded by a typical flu season, which kills tens of thousands Americans annually. But a funny thing happened in the midst of a global health pandemic: Flu season was effectively canceled.
An ardent advocate of protecting some of the world’s poorest countries from Covid-19 has been selected to lead the Biden administration’s vaccine diplomacy in an effort to corral wealthier nations into distributing immunizations more evenly around the globe.
Gayle Smith, a former U.S. Agency for International Development administrator and chief executive of the ONE Campaign to eradicate poverty and preventable disease, will step into the role, a new post at the State Department.
Recent Comments